Your 15 Minute Workday… (Make Extra Cash from Home)
Some people binge watch Netflix… Hulu…or HBO shows. And some people turn their downtime into cash. James made $2,275 in just 19 minutes…all thanks to something called The 15 Minute Workday. The average trade makes 12% in just 5 days (factoring winners and losers) which is out of this world.
Click here to start

BVS Insider Trading (Bioventus)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $32,500.00
Insider Selling (Last 12 Months): $0.00

Bioventus Insider Trading History Chart

This chart shows the insider buying and selling history at Bioventus by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bioventus Share Price & Price History

Current Price: $18.06
Price Change: Price Increase of +0.12 (0.67%)
As of 06/24/2021 04:59 PM ET

This chart shows the closing price history over time for BVS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Six Tech Stocks That Could Double
5G… blockchain… electric vehicles… There are enough tech opportunities out there to make your head spin! But which ones should you own for the coming tech boom?

Louis Navellier — the analyst who found Microsoft at .38 cents — just released a new report detailing six tech stocks to own today.

Don’t miss your chance to get his latest picks — ticker symbol and all — completely free of charge.
Click here to get your free report today.

Bioventus Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/11/2021Katrina J ChurchSVPBuy2,500$13.00$32,500.002,500View SEC Filing Icon  
See Full Table
Insider Selling at Bioventus?
Sign-up to receive's daily insider buying and selling report for Bioventus and related companies.

SEC Filings (Institutional Ownership Changes) for Bioventus (NYSE:BVS)

38.50% of Bioventus stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BVS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Bioventus Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2021Millennium Management LLC2,161,024$33.02M0.0%N/A3.803%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al139,009$2.12M0.0%N/A0.245%Search for SEC Filing on Google Icon
5/18/2021Redmile Group LLC1,500,000$22.92M0.3%N/A2.640%Search for SEC Filing on Google Icon
5/18/2021Alyeska Investment Group L.P.279,497$4.27M0.1%N/A0.492%Search for SEC Filing on Google Icon
5/18/2021Pentwater Capital Management LP55,000$0.84M0.0%N/A0.097%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System11,574$0.18M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C957,000$14.62M0.3%N/A1.684%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada2,809$43K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP205,594$3.14M0.1%N/A0.362%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP250,000$3.82M0.0%N/A0.440%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC12,422$0.19M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC30,000$0.46M0.1%N/A0.053%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC7,562$0.12M0.0%N/A0.013%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp16,101$0.25M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp93,319$1.43M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC135,001$2.06M0.0%N/A0.238%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC877,062$13.40M0.4%N/A1.543%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.21,597$0.33M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG4,288$66K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/12/2021Tamarack Advisers LP675,000$10.31M2.1%N/A1.188%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund3,400$52K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.391,826$5.99M0.0%N/A0.690%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.4,472$68K0.0%N/A0.008%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company provides osteoarthritic joint pain treatment and joint preservation products, including Durolane, a single injection therapy; GELSYN-3, a three injection therapy; and SUPARTZ FX, a five injection therapy. It also offers bone graft substitutes comprising allograft-derived bone graft with growth factors, demineralized bone matrix, cancellous bone in different preparations, bioactive synthetics, collagen ceramic matrix, and bone marrow isolation systems. In addition, the company provides Exogen systems for the non-invasive treatment of established nonunion fractures and certain fresh fractures. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Read More on Bioventus

Today's Range

Now: $18.06
Low: $17.90
High: $18.59

50 Day Range

MA: $16.26
Low: $14.05
High: $18.42

52 Week Range

Now: $18.06
Low: $10.74
High: $19.51


2,507 shs

Average Volume

205,161 shs

Market Capitalization

$1.03 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Bioventus?

Bioventus' top insider shareholders include:
  1. Katrina J Church (SVP)

Who are the major institutional investors of Bioventus?

Bioventus' top institutional shareholders include:
  1. Millennium Management LLC — 3.80%
  2. Redmile Group LLC — 2.64%
  3. Deerfield Management Company L.P. Series C — 1.68%
  4. Pura Vida Investments LLC — 1.54%
  5. Tamarack Advisers LP — 1.19%
  6. BlackRock Inc. — 0.69%

Which institutional investors are buying Bioventus stock?

In the previous quarter, BVS stock was bought by institutional investors including:
  1. Millennium Management LLC
  2. Redmile Group LLC
  3. Deerfield Management Company L.P. Series C
  4. Pura Vida Investments LLC
  5. Tamarack Advisers LP
  6. BlackRock Inc.
  7. Alyeska Investment Group L.P.
  8. Caas Capital Management LP
"I've never seen anything bigger"
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!